Anti-Human 4-1BB Therapeutic Antibody (Urelumab)
Recombinant monoclonal antibody to 4-1BB. Urelumab (ue rel' ue mab; also known as BMS-663513 and anti-4-1BB antibody) is a fully human IgG4 monoclonal antibody for the treatment of cancer and solid tumors.
Urelumab targets the CD137 receptor. It specifically binds to and activates CD137-expressing immune cells, stimulating an immune response, in particular a cytotoxic T cell response, against tumor cells.
Urelumab targets the CD137 receptor. It specifically binds to and activates CD137-expressing immune cells, stimulating an immune response, in particular a cytotoxic T cell response, against tumor cells.
Supplier | Creative Biolabs |
---|---|
Product # | TAB-179 |
Pricing | Inquiry |
Host | Human |
Target | 4-1BB |
Species Reactivity | Human |
Type | IgG4 - kappa |
Applications | ELISA, FC, IP, FuncS, IF, Neut, ICC |
Storage | At -20°C for one year. |